News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Francesco Massari: Latest Research on Immune-Based Combinations in Non–clear Cell Renal Cell Carcinoma
Francesco Massari/X
Aug 1, 2025, 21:18

Francesco Massari: Latest Research on Immune-Based Combinations in Non–clear Cell Renal Cell Carcinoma

Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, shared a post on X:

“Out now on Eur Urol Focus our ARON project latest research on Immune-based Combinations in Intermediate-/Poor-risk Patients with Non–clear Cell Renal Cell Carcinoma.
Thank to Veronica Mollica, Matteo Santoni and all Team!”

Title: Immune-based Combinations in Intermediate-/Poor-risk Patients with Non–clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study

Authors: Francesco Massari, Veronica Mollica, Ray Manneh Kopp, Enrique Grande, Ondřej Fiala, Ravindran Kanesvaran, Haoran Li, Timothy J. Schieber, Maria José Juan Fita, Alexandr Poprach, Cristian Lolli, Maria T. Bourlon, Alfonso Gómez de Liaño, Francesco Grillone, Kaisa Sunela, Alessandro Rizzo, Marwan Ghosn, Linda Cerbone, Tarek Taha, Yüksel Ürün, Javier Molina-Cerrillo, Teresa Alonso-Gordo, Edoardo Lenci, Inmaculada Orejana Martin, Hussam Abu-Sin, Pasquale Rescigno, Dipen Bhuva, Andre Poisl Fay, Vincenza Conteduca, Ahmet Yildirim, Matteo Rosellini, Umut Akova, Elisa Tassinari, Hatice Bölek, Andrey Soares, Fernando Sabino Marques Monteiro, Sebastiano Buti, Mehmet Asim Bilen, Matteo Santoni

Read the Full Article.

Francesco Massari

Ahmet Yıldırım Alessandro Rizzo Alexandr Poprach Alfonso Gómez de Liaño Andre Poisl Fay Andrey Soares ARON project cancer Cristian Lolli Dipen Bhuva Edoardo Lenci Elisa Tassinari Enrique Grande Eur Urol Focus Fernando Sabino Marques Monteiro Francesco Grillone Francesco Massari Haoran Li Hatice Bölek Hussam Abu-Sin Inmaculada Orejana Martin Javier Molina Cerrillo Kaisa Sunela Linda Cerbone María José Juan-Fita Maria T Bourlon Marwan Ghosn Matteo Rosellini Matteo Santoni Mehmet Asim Bilen OncoDaily Oncology Ondřej Fiala Pasquale Rescigno Ravindran Kanesvaran Ray Manneh Kopp Sebastiano Buti Tarek Taha Teresa Alonso-Gordo Timothy J. Schieber Umut Akova Veronica Mollica Vincenza Conteduca Yüksel Ürün
Special Coverage
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts
Radiotherapy
Aug 21, 2025, 12:31
New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test
Opinion
Aug 21, 2025, 12:03
UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH